Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00434148
Status:
COMPLETED
Last Update Posted:
2016-03-08
First Post:
2007-02-09
Brief Title:
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo Persistent or Recurrent Cushings Disease
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis